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Abstract
In the alarming context of risk of Zika virus (ZIKV) transmission in the Euro-Mediterranean area, there is a need to
examine whether capacities to detect, diagnose and notify ZIKV infections in the region are in place and whether
ongoing capacity-building initiatives are filling existing gaps.
The MediLabSecure network, created in 2014, comprises 55 laboratories of virology and medical entomology and 19
public health institutions in 19 countries in the Balkans, North-Africa, the Middle-East and the Black Sea regions. It aims
to set up awareness, risk assessment, monitoring and control of emerging and re-emerging vector-borne viruses. We
here examine the actions and strategies that MediLabSecure has been implementing and how they will contribute to
the prevention and control of the ZIKV threat in the Euro-Mediterranean area.
Capacity-building for arbovirus diagnostics is a major objective of the project and follows a methodological rather than
disease-driven approach. This enables the implementation of laboratory trainings on techniques that are common to
several arboviruses, including ZIKV, and putting into action appropriate diagnostic tools in the target region.
Moreover, by its One Health approach and the interaction of its four sub-networks in human virology, animal virology,
medical entomology and public health, MediLabSecure is fostering intersectoral collaboration, expertise and sharing of
information. The resulting exchanges (methodological, communication and operational) across disciplines and across
countries, dedicated research on intersectoral collaboration and increasing diagnostic capacities are providing new
paths and tools to public health professionals to face emerging viral threats such as a ZIKV epidemic in the Euro-
Mediterranean region.
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Background
Due to the link between Zika virus (ZIKV) infection and
neurological disorders/neonatal malformations, the
WHO acknowledged the ongoing ZIKV outbreak as a
public health emergency of international concern (PHEIC)
[1–4]. At least three factors are necessary to enable the
onset of an outbreak of mosquito-borne viral infections in
humans: (i) presence of the virus; (ii) susceptibility of hu-
man populations to the virus; (iii) presence of populations
of anthropophilic vectors with suitable vectorial capacity
[5]. Therefore, these three factors need to be considered
while assessing the risk of a ZIKV outbreak occurring in
the Euro-Mediterranean area. The presence of the virus is
now demonstrated in the region as a corollary of
globalization and increasing international travelers’ traffic
[6–8]. In addition, the human population is assumed to be
largely susceptible with the marginal exclusion of the few
naturally immunized travelers infected in endemic/
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epidemic areas. Finally, as we will discuss in this paper,
there is a high probability of the presence in this geo-
graphical region of vector populations that have demon-
strated a suitable vectorial capacity to ZIKV.
Indeed, ZIKV has been isolated from a variety of mos-
quito species, mainly of the Aedini tribe (among which
the subgenera Stegomyia, Diceromyia and Aedimorphus
of the genus Aedes) [9, 10], indicating a mild specificity
between the mosquito host and the virus. These findings
strongly suggest that the Stegomyia mosquitoes, includ-
ing the invasive tiger mosquito Aedes albopictus that is
spreading in the Euro-Mediterranean and Black Sea area
[11, 12], comprises vector populations with a sufficiently
high vectorial capacity to allow ZIKV transmission.
Considering this alarming context, the ECDC recently
issued a ZIKV risk assessment for continental Europe, es-
timating an increasing number of travel-related reported
ZIKV infections, and indicating a risk of transmission
from imported cases by the Aedes albopictus mosquito
species [13], now established in many parts of the Euro-
pean Union (EU), primarily around the Mediterranean
[14]. This finding raises the issue of whether capacities to
detect, diagnose and notify ZIKV infections in the region
are in place and whether ongoing capacity-building initia-
tives are filling existing gaps.
In order to enhance preparedness to common health
threats and biosafety risks, the EU supported the cre-
ation of the MediLabSecure network of human, veterin-
ary and medical entomology laboratories and public
health institutions which aims to support target coun-
tries to set up awareness, risk assessment, monitoring
and control of emerging and vector-borne viruses of
concern in the region. This network was created in 2014
as a continuation of a prior network developed by the
EpiSouth and EpiSouth Plus Projects [15, 16] on the
basis of the common needs and challenges shared by the
countries bordering the Mediterranean Basin in the field
of surveillance and control of infectious diseases and
other threats to health. The strategies adopted by the
EpiSouth Network were positively assessed by both
internal and external evaluators during its implemen-
tation [17, 18] and its added value has been inter-
nationally recognized and rewarded with the 2014
European Health Award as “the Mediterranean pro-
ject to counteract cross-border threats to health” [19].
Today, the MedilabSecure Network comprises 55 la-
boratories and 19 public health institutions/Ministries
of Health in 19 non-EU countries in the Mediterranean
and Black Sea regions (Fig. 1).
This One Health project rotates around the interaction
of four sub-networks: one for human health, one for ani-
mal health, one for medical entomology and one for
public health. This approach targets viral threats that
can have a great impact on human and/or animal health.
The purpose of this correspondence is to present the
actions and strategies that MediLabSecure is implement-
ing and how they can now contribute to the prevention
and control of the ZIKV threat. We aim to highlight
how, although established prior to the current crisis,
MediLabSecure has been implementing a number of
WHO recommendations included in the ZIKV PHEIC
Declaration [4] under a One Health perspective.
Capacity-building activities impacting Zika virus
preparedness
The overall MediLabSecure objectives are: (i) identify
the needs of the different target laboratories by assess-
ment tools, (ii) design and implement tailored training
sessions accordingly, (iii) complement with expert visits
and quality assessments and (iv) strengthen intersectoral
collaborations between the human, animal and ento-
mological sectors involved in vector-borne diseases
surveillance. This objective is addressed by holding
multidisciplinary “One Health” activities such as joint
meetings, technical transversal workshops, expert visits
where representatives of the four networks interact at na-
tional and international levels to foster mutual cooper-
ation and intersectoral risk assessment exercises and
tailored research to explore how this intersectoral collab-
oration is implemented within partner countries.
To date, the MediLabSecure human virology sub-
network, under the leadership of the Institut Pasteur in
Paris, conducted three workshops on scientific know-
ledge and technical skills (real-time RT-PCR and ser-
ology by ELISA) for the detection of arbovirus
infections. While specific diagnostic capacity for ZIKV
in terms of reagents and reference protocols was not ini-
tially an aim of this project, the MediLabSecure human
virology sub-network reacted to this new public health
context and, by January 2016, ZIKV real-time RT-PCR
protocols were shared and required reagents including
positive controls were distributed within the network.
Information regarding the availability and performance
of diagnostic tools and reference protocols as well as
accurate testing algorithms are shared and regularly
updated.
The MediLabSecure animal virology sub-network,
under the leadership of the Animal Health Research
Centre (INIA-CISA, Spain), is working to enhance pre-
paredness of veterinary laboratories to face health threats
caused by emerging viral pathogens, most of them zoo-
notic in nature. Technical workshops, experts’ exchanges,
scientific visits and external quality assessment exercises
are performed to improve the capacities of the laborator-
ies to diagnose zoonotic viral infections in animals, with
special focus on arboviruses. Finally, the overall objectives
are completed by promoting continuous contact and ex-
change of information not only between veterinary
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laboratories from the different participating countries, but
also within the different sub-networks, in-line with the
adopted “One Health” perspective.
Although ZIKV is not regarded as a zoonotic agent,
there are still a number of uncertainties around its
host range and life cycle. For instance, there is evi-
dence that bats could play a role in ZIKV infectious
cycle [20]. More studies are needed to clarify the in-
volvement of animal hosts on ZIKV epidemiology and
its possible role in animal disease. In case new studies
would reveal the involvement of other vertebrates in
ZIKV infectious cycle, appropriate detection and con-
trol tools would be rapidly disseminated and imple-
mented through the animal virology network based
on previously shared protocols and techniques taught
during the workshops.
The MediLabSecure medical entomology sub-
network, under the leadership of the Research and
Development Institute (IRD, France), focuses mainly on
mosquitoes identified as present threats for arbovirus
transmission but also with potential risk of emergence in
the Mediterranean and Black Sea regions. Expert visits,
and training modules have been implemented and
mosquito identification tools have been devised. Three
one-week training sessions have enabled at least two en-
tomologists from each of the 19 laboratory members to
increase practical competencies concerning mosquito
vectors of arboviruses (field sampling, species determin-
ation, surveillance systems) and to enhance regional
cooperation.
In view of strengthening integration across disci-
plines for surveillance of vector-borne diseases, the
MediLabSecure public health sub-network designed
a framework to define, study and promote intersec-
toral integration of surveillance from a One Health
perspective through a systematic literature review, a
survey involving all the sub-networks in all 19 coun-
tries [21] and the MediLabSecure Situation Analysis
Study. Preliminary findings were consolidated during a
public health workshop where 73 representatives of all the
described sub-networks were engaged in an exercise on
intersectoral WNV risk assessment and SWOT analysis.
While not specifically addressing ZIKV surveillance, this
work has involved the same professionals currently
Fig. 1 MediLabSecure network partner countries (n = 19) and project partners : Institut Pasteur, Paris, France (project coordination and human
virology), National Centre for Epidemiology, Surveillance and Health Promotion, Italy (public health), Instituto Nacional de Investigación y
Tecnologia Agraria y Alimentaria, Centro de Investigación en Sanidad Animal (INIA-CISA), Madrid, Spain (animal virology), Institut de Recherche
pour le Développement, Montpellier, France (medical entomology). Figure 1 is produced by the authors of the present manuscript
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engaged in the detection of ZIKV infections from a viro-
logical, entomological and public health perspective and
created a unique opportunity for team building, exchange
of expertise and information across the different sectors
and countries.
Conclusion
The current ZIKV emergence has highlighted the need to
conduct comprehensive risk assessments, establish effective
monitoring programs, develop preparedness activities and
implement adequate control measures with regard to arbo-
viral threats in the Euro-Mediterranean area. Thanks to its
One Health framework integrating four sub-networks in-
volved in the monitoring, prevention and control of arbo-
viral diseases from different perspectives, MediLabSecure is
fostering collaboration, networking and timely sharing of
information, across disciplines and across countries. In fact,
as also discussed by other authors [22], the desired impact
of the One Health approach expected through intersectoral
integration can only be achieved if also the capacities of
each involved sector are sufficiently strong and developed.
MedilabSecure is working with a comprehensive strategy
addressing both the capacity of the single sector and the
intersectoral integration.
The resulting exchanges and capacity-building are now
facilitating the step-up of intersectoral regional capaci-
ties in the face of emerging viral threats in a methodo-
logical rather than disease driven approach. Therefore,
after having developed the basic methodological skills
across the region, the network is now in the position to
fill gaps in ZIKV detection capacity, by putting into ac-
tion harmonized diagnostic tools and algorithms, vector
sampling and identification methods and control mea-
sures, within a conducive intersectoral framework which
constitutes an asset towards preparedness to any present
or emerging threats to human and/or animal health.
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